VASCULARIZED COMPOSITE ALLOGRAFTS ( L CENDALES AND R BARTH , SECTION EDITORS ) Report ( 2017 ) of the International Registry on Hand and Composite Tissue Allotransplantation ( IRHCTT )

[1]  A. Ramirez,et al.  Immunosuppression maintenance in vascularized composite allotransplantation: what is just right? , 2017, Current opinion in organ transplantation.

[2]  Ping Fang,et al.  Molecular characterization and copy number of SMN1, SMN2 and NAIP in Chinese patients with spinal muscular atrophy and unrelated healthy controls , 2015, BMC Musculoskeletal Disorders.

[3]  C. Ensor,et al.  Characterization, Prophylaxis, and Treatment of Infectious Complications in Craniomaxillofacial and Upper Extremity Allotransplantation: A Multicenter Perspective , 2014, Plastic and reconstructive surgery.

[4]  S. Hammond.  Infections in composite tissue allograft recipients. , 2013, Infectious disease clinics of North America.

[5]  M. Siemionow,et al.  Face Transplantation: Outcomes, Concerns, Controversies, and Future Directions , 2012, The Journal of craniofacial surgery.

[6]  S. Trigg.  The International Registry on Hand and Composite Tissue Transplantation , 2011 .

[7]  F. Schuind,et al.  The International Registry on Hand and Composite Tissue Transplantation , 2005, Transplantation.

[8]  T. Pruett.  The Banff 2007 Working Classification of Skin-Containing Composite Tissue Allograft Pathology , 2009 .

[9]  Frédéric Schuind,et al.  The International Registry on Hand and Composite Tissue Transplantation , 2010, Transplantation.

[10]  P. Petruzzo,et al.  A Comprehensive Functional Score System in Hand Transplantation , 2007 .

[11]  C. Ekdahl,et al.  The disabilities of the arm, shoulder and hand (DASH) outcome questionnaire: longitudinal construct validity and measuring self-rated health change after surgery , 2003, BMC musculoskeletal disorders.